Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11894-017-0543-3.pdf
Reference31 articles.
1. • Tapper EB. Building effective quality improvement programs in liver disease: a systematic review of quality improvement initiatives. Clin Gastroenterol Hepatol. 2016. A systematic review of quality improvement initiatives for patients with cirrhosis highlights the common features of successful and unsuccessful programs.
2. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107(2):247–52.
3. •• Tapper EB, Halbert B, Mellinger J. Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study. Clin Gastroenterol Hepatol. 2016. The first population-based cohort study on readmsisions. It established that readmission risk is proportional to the number of hepatic decompensations, most linked to hepatic encephalopathy overall and substance abuse-related admissions among non-decompensated patients with alcoholic cirrhosis.
4. Bajaj JS, O’Leary JG, Reddy KR, Wong F, Olson JC, Subramanian RM, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end‐stage liver disease (NACSELD) experience. Hepatology. 2012;56(6):2328–35.
5. Tapper EB, Risech-Neyman Y, Sengupta N. Psychoactive medications increase the risk of falls and fall-related injuries in hospitalized patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13(9):1670–5.
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preventing Readmissions of Hepatic Encephalopathy;Clinics in Liver Disease;2024-05
2. Population characteristics, healthcare pathways and outcomes of patients with cirrhosis hospitalized with overt hepatic encephalopathy in France: A study of the French Hospital‐Discharge Database;Clinics and Research in Hepatology and Gastroenterology;2024-03
3. Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis;World Journal of Hepatology;2023-06-27
4. Enhanced In Vitro Cytotoxicity and In Vivo Nursing Care of Gastric Cancer Cells by Nanoparticles Bearing Platinum (IV) Prodrug of Cisplatin;Journal of Biomedical Nanotechnology;2023-03-01
5. Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers;Hepatology Communications;2023-01-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3